Monday, July 4, 2022

561.316.3330

Hekka Labs Introduces the First Decentralized Chronic Disease Data Management Ecosystem in South Asia

Providing a transformational health care data management ecosystem using blockchain technology to solve multiple pain points in managing healthcare data

Latest Posts

Worldwide Biopharmaceuticals Contract Manufacturing Industry is Expected to Reach $67.9 Billion by 2027

The Global Biopharmaceuticals Contract Manufacturing Market size was estimated at USD 27.99 billion in 2021 and expected to reach USD 32.37 billion in 2022, and is projected to grow at a CAGR 15.92% to reach USD 67.93 billion by 2027.

Global Chromatography Accessories and Consumables Market Analysis Report 2022: Market to Reach $14.7 Billion by 2027

Amid the COVID-19 crisis, the global market for Chromatography Accessories and Consumables market estimated at US$10.1 Billion in the year 2020, is projected to reach a revised size of US$14.7 Billion by 2027, growing at a CAGR of 5.5% over the analysis period 2020-2027.

Lupus Nephritis Market Insight, Epidemiology and Market Forecast 2032

In the coming years, the Lupus Nephritis market is set to change due to the rising awareness of the disease, and incremental healthcare spending across the world; which would expand the size of the market to enable the drug manufacturers to penetrate more into the market.

ROME Therapeutics Announces Publication of First Crystal Structure of a Human Endogenous Reverse Transcriptase in PNAS

ROME Therapeutics notes the study reveals first-ever structure of a non-viral endogenous reverse transcriptase. Human endogenous retrovirus-K (HERV-K) RT shows striking similarity to HIV RT. The findings enable structure-based drug discovery for eRTs

Hekka Labs launches a game-changing decentralized healthcare ecosystem for a far more efficient health record management. The firm will concentrate on the Southeast Asia market, starting with India, where it will establish the largest chronic disease data management network. Hekka then intends to connect to the rest of the world’s healthcare market through the design and implementation of proprietary Distributed Ledger Technology (DLT).

Hekka has cemented initial partnerships with 3 Indian healthcare solution providers, Curisin, a healthcare company with a wide network of 30 million patients and 40,000 partnered doctors which as recently agreed to provide a minimum of 1.5 million medical records in 2022. A further agreement to provide up to 20 separate blood biomarkers together with Covid 19 data on 100,000 patients, will form the basis of an initial trial for its blockchain audit trail platform. IMMUNIDEX, a healthcare solution provider offering tests and applications that are driven by proprietary AI that can identify early immune-related risks and is well placed to capture highly valuable data for the Hekka network. TELEMEDICINE INDIAN CO, a start-up offering multi telemedicine services, multiple blood tests, and health screening including COVID-19 testing will form another integral part of data generation for the Hekka ecosystem.

Hekka Labs with the integration of Distributed Ledger Technology (DLT) offers a plug and go solution that allows users to interact with the HEKKA ecosystem without major disruption. This set up can solve the inherent problems that occur on a regular basis in the healthcare industry such as inefficient biomarker management, document hogging and unstructured data management.

Hekka Labs has set out to become the leading chronic illness and immunology platform in India. Hekka’s private and public blockchain network solution will generate a new trust in Indian healthcare data management and can open up significant opportunity for both the domestic and global collaboration. This will lead to new levels of ethical standards and excellence for the Indian healthcare market.

In the long run, Hekka plans to evolve as a significant decentralized healthcare ecosystem by connecting the network of medical and associated healthcare providers culminating in a targeted community of over 500 million patients. As a result, tens of billions of chronic disease digital biomarkers can be made available for Deep Learning, potentially speeding up new healthcare discoveries.

HEK is the native token of the Hekka ecosystem, which is launched in the Ethereum network’s ERC-20 standards for its intensive security and global reputation, ensuring the confidence of delivering the most sophisticated healthcare data management service.

The HEK token is a token complimented by an ATOM token (Points) system which is the primary source of HEKKA ‘s data transfers. This ensures the value of the token. The HEK token will be a key component in serving all prospective users’ interactions with the platform’s different levels of service.

Latest Posts

Learn More

spot_img

Subscribe

spot_img

Our Sister Publication

Medical Device News Magazine